Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome.
PARD3 dysfunction in conjunction with dynamic HIPPO signaling drives cortical enlargement with massive heterotopia.
Radiotherapy-induced common carotid pseudoaneurysm presenting with initially occult upper airway hemorrhage and successfully treated by endovascular stent graft.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 02 08; 378(6):518-528.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Bortezomib
Disease-Free Survival
Female
Follow-Up Studies
Humans
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Melphalan
Middle Aged
Multiple Myeloma
Prednisone
Survival Rate
authors with profiles
Andrzej Jakubowiak